News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hirmand Mohammad
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/17/2022 |
4
| Hirmand Mohammad (EVP and Chief Medical Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 41,284 shares
@ $76, valued at
$3.1M
Disposed/sold 169,192 options to buy
@ $54.73, valued at
$9.3M
Disposed/sold 29,175 options to buy
@ $140.01, valued at
$4.1M
Disposed/sold 68,367 options to buy
@ $37.68, valued at
$2.6M
|
|
| 02/11/2022 |
4
| Hirmand Mohammad (EVP & Chief Medical Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 669 shares
@ $36.3, valued at
$24.3k
Granted 18,983 shares
@ $0
Granted 15,000 shares
@ $0
Granted 68,367 options to buy
@ $37.68, valued at
$2.6M
|
|
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Hirmand Mohammad (EVP and Chief Medical Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 300 shares
@ $122.44, valued at
$36.7k
Sold 8,747 shares
@ $120.42, valued at
$1.1M
Sold 1,253 shares
@ $120, valued at
$150.4k
Exercised 8,747 options to buy
@ $54.73, valued at
$478.7k
Exercised 1,253 options to buy
@ $54.73, valued at
$68.6k
|
|
| 12/03/2019 |
4
| Hirmand Mohammad (EVP and Chief Medical Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 179,192 options to buy
@ $54.73, valued at
$9.8M
|
|
| 12/03/2019 |
3
| Hirmand Mohammad (EVP and Chief Medical Officer) has filed a Form 3 on Turning Point Therapeutics, Inc. |
| 09/30/2016 |
4
| Hirmand Mohammad (Interim Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Unknown transaction of 39,068 shares
@ $0
Disposed/sold 18,684 shares
@ $0
Disposed/sold 24,000 options to buy
@ $8.64, valued at
$207.4k
Disposed/sold 60,000 options to buy
@ $3.7925, valued at
$227.6k
Disposed/sold 16,880 options to buy
@ $27.43, valued at
$463k
Disposed/sold 11,740 options to buy
@ $35.955, valued at
$422.1k
Disposed/sold 3,460 options to buy
@ $52.85, valued at
$182.9k
Disposed/sold 13,560 options to buy
@ $60.525, valued at
$820.7k
Disposed/sold 2,380 options to buy
@ $42.5, valued at
$101.2k
Disposed/sold 38,530 options to buy
@ $35.77, valued at
$1.4M
Disposed/sold 1,120 options to buy
@ $46.45, valued at
$52k
|
|
| 09/19/2016 |
4
| Hirmand Mohammad (Interim Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Exercised 5,620 options to buy
@ $4.0025, valued at
$22.5k
Exercised 11,940 options to buy
@ $4.6925, valued at
$56k
|
|
| 04/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2016 |
4
| Hirmand Mohammad (Interim Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 1,525 shares
@ $41.1047, valued at
$62.7k
|
|
| 03/02/2016 |
4
| Hirmand Mohammad (Interim Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Granted 9,300 shares
@ $0
Granted 38,530 options to buy
@ $35.77, valued at
$1.4M
|
|
|
|